Drug Search Results
More Filters [+]

AS-02

Alternative Names: as-02, as02, as 02
Latest Update: 2024-11-12
Latest Update Note: News Article

Product Description

HB-AS 02 is an investigational adjuvanted hepatitis B virus (HBV) vaccine for potential use in patients with renal insufficiency and other immunocompromised individuals.

Mechanisms of Action: Vaccine

Novel Mechanism: No

Modality: Vaccine

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: GlaxoSmithKline
Company Location: BRENTFORD MIDDLESEX X0 TW8 9GS
Company CEO: Emma Walmsley
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for AS-02

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Malaria, Falciparum

Phase 1: Tuberculosis

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

NCT00291889

P1

Completed

Tuberculosis

2005-05-01

MAL019

P2

Completed

Malaria, Falciparum

2002-02-01

Recent News Events